Recently Viewed

    abnormalreturns

    Tadas Viskanta Official Account Joined Aug 14, 2009

    Tadas Viskanta, Founder and Editor of Abnormal Returns. Author of Abnormal Returns: Winning Strategies from the Frontlines of the Investment Blogosphere.

    Following

    1. Thumb-1314303895
      gtotoy
      Ronald Roll
      DayTraderBootCamp.Com
    2. Thumb-1267063379
      WallStreetBean
      Daniel Miller
      Master of the BeanScreen.
    3. Thumb-1382630308
      allstarcharts
      J.C. Parets Official Account
      Founder of Eagle Bay Capital & Market Technician. For info on Managed Assets see: http://www.eaglebaysolutions.com/managed-assets/ For Premium Service see: http://www.eaglebaysolutions.com
    4. Thumb-1312391472
      cjbullock
      Chris Bullock
    5. Thumb-1308750462
      EQT_IR
      EQT Corporation
      EQT Corporation (NYSE: EQT) conducts its business through three business segments: EQT Production, EQT Midstream and Distribution. EQT has 5.2 Tcfe of proved reserves in the Appalachian Basin.
    6. Thumb-1308167821
      OracleIR
      Ken Bond Official Account
    7. Thumb-1308245156
      MedAssetsIR
      MedAssets, Inc.
    8. Thumb-1308249609
      AvisBudgetIR
      Avis Budget Group, Inc.
    9. Thumb-1355436672
      SHFL_News
      SHFL entertainment, Inc. Official Account
      SHFL Investor Relations: Providing news on $SHFL for the investment community.
    10. Thumb-1308317364
      Shell
      Royal Dutch Shell plc Official Account
      Shell is a global group of energy and petrochemicals companies. With around 90,000 employees in more than 80 countries and territories, Shell helps to meet the world's growing demand for energy in economically, environmentally and socially responsibl
    11. Thumb-1308252660
      NuPatheIR
      NuPathe Inc. Official Account
      NuPathe Inc. is a specialty pharmaceutical company focused on innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders.
    12. Thumb-1308345707
      BridgepointEd
      Bridgepoint Education, Inc.
    13. Default_avatar_thumb
      RCII_investor
      Rent-A-Center
    14. Thumb-1308582110
      AEP
      AEP Official Account
      AEP ranks among the nations largest generators of electricity, owning nearly 38,000 megawatts of generating capacity in the U.S. AEP also owns the nations largest electricity transmission system, and serves 5.3 customers in 11 states.
    15. Thumb-1311629095
      MeritageHomes_IR
      Meritage Homes Corp
      Brent Anderson is the Vice President Investor Relations with Meritage Homes since 2005. He has a BS in Finance & Accounting from University of North Dakota. Brent is a member of the AICPA and NIRI-DFW chapter president.
    16. Thumb-1308678060
      Molycorp
      Molycorp
      Colorado-based Molycorp, Inc. is the only REO producer in the Western Hemisphere and currently produces more than 3,000 metric tons of commercial rare earth materials per year. In addition to its flagship rare earth mine and processing facility a
    17. Thumb-1308861089
      SyscoStock
      Sysco Official Account
      Sysco (NYSE: SYY) is the global leader in marketing and distributing food products to the foodservice and hospitality industries. http://www.sysco.com/investors
    18. Thumb-1308866546
      TesseraTech
      Tessera Technologies
      Tessera Technologies, Inc., headquartered in San Jose, California, develops, invests in, licenses and delivers innovative miniaturization technologies and products for next-generation electronic devices. More than 65% of Tessera's employees are dedic
    19. Thumb-1339767503
      hillenbrandir
      Shari Morey
      Hillenbrand is a global diversified industrial company that makes and sells premium business-to-business products and services for a wide variety of industries. We pursue profitable growth and meaningful dividends for our shareholders by leveraging o
    20. Thumb-1300275219
      ventrusbio
      ventrusbio Official Account
      VTUS is a development stage specialty pharmaceutical company focused on the development of late-stage prescription drugs for gastrointestinal disorders, specifically hemorrhoids, anal fissures and fecal incontinence.